Join us at the annual International Stroke Conference next February in Los Angeles!
📌ETAP-Lab is delighted to present for the first time a poster at the American Heart Association’s annual International Stroke Conference 2025, in Los Angeles, CA from February 5 to 7, 2025.
As a leading international conference in cerebrovascular disease and brain health, the AHA’s International Stroke Conference was the ideal platform to highlight our preclinical stroke research expertise.
ETAP-Lab, preclinical efficacy CRO, will be presenting its poster on original preclinical results about in vivo trials on Stroke disease.
đź“…Meet our expert during the poster session
Annelise LETOURNEUR, Director of Operations at STROK@LLIANCE and Neuroscience Study Director, will present the poster “ Translational Relevance and Versatility of the Thromboembolic Stroke Model in Mice: Implications for Pharmacological and Safety Evaluations” (#4166454).
Session details to come sooner.
🧠Our specific stroke models, reproducing translational challenges.
Would you like to support the development of your neurological drugs with translational preclinical models?
Thanks to our robust expertise in preclinical neurology, we can advise with relevant and translatable range of stroke models from in vitro to in vivo. Our key innovation is to offer models in optimal translational situations that combine stroke with metabolic diseases, diabetes or aging.
More to discover:
- Register now to the conference: https://professional.heart.org/en/meetings/international-stroke-conference/registration
- Have a look at our wide range of models in Neurology field and especially in stroke!
- You can connect with us and ask for the poster in PDF.
- Discover STROK@LLIANCE, our lab dedicated to stroke research in France
